Header Logo

Connection

Kamyar Kalantar-Zadeh M.D. to Parathyroid Hormone

This is a "connection" page, showing publications Kamyar Kalantar-Zadeh M.D. has written about Parathyroid Hormone.
  1. Racial-ethnic differences in chronic kidney disease-mineral bone disorder in youth on dialysis. Pediatr Nephrol. 2019 01; 34(1):107-115.
    View in: PubMed
    Score: 0.593
  2. Comparative mortality-predictability using alkaline phosphatase and parathyroid hormone in patients on peritoneal dialysis and hemodialysis. Perit Dial Int. 2014 Nov-Dec; 34(7):732-48.
    View in: PubMed
    Score: 0.427
  3. Correlates of parathyroid hormone concentration in hemodialysis patients. Nephrol Dial Transplant. 2013 Jun; 28(6):1516-25.
    View in: PubMed
    Score: 0.400
  4. Target levels for serum phosphorus and parathyroid hormone. Semin Dial. 2011 Jan-Feb; 24(1):29-33.
    View in: PubMed
    Score: 0.350
  5. Insights into nutritional and inflammatory aspects of low parathyroid hormone in dialysis patients. J Ren Nutr. 2011 Jan; 21(1):100-4.
    View in: PubMed
    Score: 0.347
  6. Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients. J Ren Nutr. 2010 Jul; 20(4):243-54.
    View in: PubMed
    Score: 0.327
  7. Ratio of paricalcitol dosage to serum parathyroid hormone level and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2008 Nov; 3(6):1769-76.
    View in: PubMed
    Score: 0.294
  8. Calcium Transport in the Kidney and Disease Processes. Front Endocrinol (Lausanne). 2021; 12:762130.
    View in: PubMed
    Score: 0.188
  9. Parenteral iron therapy and phosphorus homeostasis: A review. Am J Hematol. 2021 05 01; 96(5):606-616.
    View in: PubMed
    Score: 0.175
  10. Association of Mineral Bone Disorder With Decline in Residual Kidney Function in Incident Hemodialysis Patients. J Bone Miner Res. 2020 02; 35(2):317-325.
    View in: PubMed
    Score: 0.160
  11. Changes in serum albumin and other nutritional markers when using sucroferric oxyhydroxide as phosphate binder among hemodialysis patients: a historical cohort study. BMC Nephrol. 2019 10 29; 20(1):396.
    View in: PubMed
    Score: 0.160
  12. Seasonal variation of serum 25-hydroxyvitamin D and parameters of bone and mineral disorder in dialysis patients. Bone. 2019 07; 124:158-165.
    View in: PubMed
    Score: 0.153
  13. The Role of Vitamin D in CKD Stages 3 to 4: Report of a Scientific Workshop Sponsored by the National Kidney Foundation. Am J Kidney Dis. 2018 12; 72(6):834-845.
    View in: PubMed
    Score: 0.148
  14. Association of Parameters of Mineral Bone Disorder with Mortality in Patients on Hemodialysis according to Level of Residual Kidney Function. Clin J Am Soc Nephrol. 2017 Jul 07; 12(7):1118-1127.
    View in: PubMed
    Score: 0.135
  15. Development and Validation of a Novel Laboratory-Specific Correction Equation for Total Serum Calcium and Its Association With Mortality Among Hemodialysis Patients. J Bone Miner Res. 2017 Mar; 32(3):549-559.
    View in: PubMed
    Score: 0.130
  16. Successful Conversion From Parenteral Paricalcitol to Pulse Oral Calcitriol for the Management of Secondary Hyperparathyroidism in Hemodialysis Patients. J Ren Nutr. 2016 07; 26(4):265-9.
    View in: PubMed
    Score: 0.125
  17. Changes in Markers of Mineral and Bone Disorders and Mortality in Incident Hemodialysis Patients. Am J Nephrol. 2016; 43(2):85-96.
    View in: PubMed
    Score: 0.124
  18. Alkaline phosphatase: better than PTH as a marker of cardiovascular and bone disease? Hemodial Int. 2014 Oct; 18(4):720-4.
    View in: PubMed
    Score: 0.112
  19. Mortality of combined serum phosphorus and parathyroid hormone concentrations and their changes over time in hemodialysis patients. Bone. 2014 Apr; 61:201-7.
    View in: PubMed
    Score: 0.107
  20. Impact of age on survival predictability of bone turnover markers in hemodialysis patients. Nephrol Dial Transplant. 2013 Oct; 28(10):2535-45.
    View in: PubMed
    Score: 0.104
  21. Administered paricalcitol dose and survival in hemodialysis patients: a marginal structural model analysis. Pharmacoepidemiol Drug Saf. 2012 Nov; 21(11):1232-9.
    View in: PubMed
    Score: 0.098
  22. Diuretics and secondary hyperparathyroidism in chronic kidney disease. Nephrol Dial Transplant. 2011 Apr; 26(4):1122-5.
    View in: PubMed
    Score: 0.088
  23. Association of cumulatively low or high serum calcium levels with mortality in long-term hemodialysis patients. Am J Nephrol. 2010; 32(5):403-13.
    View in: PubMed
    Score: 0.085
  24. Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals. Kidney Int Suppl. 2010 Aug; (117):S10-21.
    View in: PubMed
    Score: 0.084
  25. Impact of race on hyperparathyroidism, mineral disarrays, administered vitamin D mimetic, and survival in hemodialysis patients. J Bone Miner Res. 2010 Dec; 25(12):2724-34.
    View in: PubMed
    Score: 0.084
  26. Cinacalcet lowers serum alkaline phosphatase in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2009 Mar; 4(3):673-9.
    View in: PubMed
    Score: 0.076
  27. Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. J Am Soc Nephrol. 2008 Nov; 19(11):2193-203.
    View in: PubMed
    Score: 0.073
  28. Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease. Kidney Int. 2008 Jun; 73(11):1296-302.
    View in: PubMed
    Score: 0.071
  29. Vitamin D receptor activation and survival in chronic kidney disease. Kidney Int. 2008 Jun; 73(12):1355-63.
    View in: PubMed
    Score: 0.071
  30. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int. 2006 Aug; 70(4):771-80.
    View in: PubMed
    Score: 0.063
  31. Comparative Effectiveness of Dialysis Modality on Laboratory Parameters of Mineral Metabolism. Am J Nephrol. 2022; 53(2-3):157-168.
    View in: PubMed
    Score: 0.047
  32. Race and Ethnicity Predict Bone Markers and Fracture in Pediatric Patients With Chronic Kidney Disease. J Bone Miner Res. 2021 02; 36(2):298-304.
    View in: PubMed
    Score: 0.043
  33. Using a web-based nutrition algorithm in hemodialysis patients. J Ren Nutr. 2015 Jan; 25(1):6-16.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.